This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 09/16/2020
Location: Virtual
Subject: Health Evolution Roundtable on Next Generation IT in Health Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academics, and other invited stakeholders

Event Date: 09/16/2020
Location: Virtual
Subject: Electronic Health Record Data in Clinical Evidence Development
FDA Participant/Group: LAURA ROE; JOSEPH FRANKLIN;
Non FDA Participant/Group: Adrian Cassidy, Bertrand Bodson, Jeremy Sohn, Raj Patil, Rob Kowalski, Shahram Ebadollahi (Novartis);

Event Date: 09/17/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, health care providers, industry, academia, and other stakeholders

Event Date: 09/17/2020
Location: Virtual
Subject: International Society for Pharmacoepidemiology (ICPE) All Access Session: Real-World Evidence and COVID-19
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academics, and other stakeholders

Event Date: 09/17/2020
Location: Virtual
Subject: Getting Real World Data About COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, media, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 09/16/2020
Location: Webinar
Subject: Food and Drug Law Institute; Continued Reliance on Foreign Drug Manufacturing and the Drug Supply Chain: Manageable Risk or Public Health Concern?
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Members of Food and Drug Law Institute (FDLI)

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 09/14/2020
Location: Virtual
Subject: Food Safety and COVID-19 Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several executives from the Food and Beverage Association

Event Date: 09/16/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: CAITLIN BOON; LARRY MORRIS;
Non FDA Participant/Group: Kyle Kinner, Sandra Eskin (The Pew Charitable Trusts);

Event Date: 09/16/2020
Location: Virtual
Subject: Marsh Food and Beverage Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the food and beverage industry

Event Date: 09/17/2020
Location: Virtual
Subject: Food Safety Culture
FDA Participant/Group: DONALD PRATER; CONRAD CHOINIERE;
Non FDA Participant/Group: Several members from the Partnership for Food Safety Education

Event Date: 09/18/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA senior officials and staff
Non FDA Participant/Group: Several members from the produce industry to include growers, shippers, trade associations, and academia

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 09/14/2020
Location: Teleconference
Subject: Medical Devices
FDA Participant/Group: N/A
Non FDA Participant/Group: Andrzej Rys (European Commission);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/14/2020
Location: Virtual
Subject: 2020 Parenteral Drug Association / FDA Joint Regulatory Conference; COVID-19 Vaccine Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, government, and other registered guests

Event Date: 09/16/2020
Location: Virtual
Subject: 2020 Parenternal Drug Association / FDA Joint Regulatory Conference; CBER Center Update - Center Director Panel
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, government, and other registered guests

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 09/15/2020
Location: Virtual
Subject: Regulatory Affairs Professionals' Society: CDRH Town Hall
FDA Participant/Group: BINITA ASHAR; WILLIAM MAISEL; DANIEL CANOS; ELI TOMAR; HEATHER AGLER; MICHELLE TARVER; TIMOTHY STENZEL;
Non FDA Participant/Group: Regulatory affairs professionals

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event